# Nippon Kayaku Pharmatech Co., Ltd. – FDA Inspection, Nov 25, 2022

Source: https://www.keypedia.com/records/fda_inspections/nippon-kayaku-pharmatech-co-ltd/7595fc4c-3ff0-4fc0-b834-27f05930500e
Source feed: FDA_Inspections

> FDA inspection 1192063 of Nippon Kayaku Pharmatech Co., Ltd., November 25, 2022. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1192063
- Company Name: Nippon Kayaku Pharmatech Co., Ltd.
- Inspection Date: 2022-11-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1335048 - 2026-09-04](https://www.keypedia.com/records/fda_inspections/nippon-kayaku-pharmatech-co-ltd/77bf1560-ef7b-4938-a61e-dbd109da0aef)

Company: https://www.keypedia.com/companies/nippon-kayaku-pharmatech-co-ltd/88530942-e172-4a65-8c32-4495fdaa6b61

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c